Dr Reddys Laboratories (RDY) Goodwill (2009 - 2026)

Dr Reddys Laboratories (RDY) has reported Goodwill for 11 consecutive years, with $137.0 million the latest figure, recorded in Q1 2026.

• Quarterly Goodwill fell 0.72% year-over-year to $137.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $137.0 million (down 0.72% YoY) and the FY2026 annual result came in at $137.0 million, down 0.72% from the prior year.
• Goodwill fell to $137.0 million in Q1 2026 per RDY's latest filing, from $138.0 million in the prior quarter.
• Over the last five years, Goodwill for RDY reached as high as $138.0 million in Q1 2025 and fell as low as $51.0 million in Q1 2024.
• A 5-year average of $87.2 million and a median of $58.0 million in 2022 frame the typical range for Goodwill.
• Annual changes were most pronounced in 2023 — Goodwill decreased 10.34% — and 2025, when it soared 170.59%.
• Year by year, Goodwill stood at $58.0 million in 2022, then declined by 10.34% to $52.0 million in 2023, then slipped by 1.92% to $51.0 million in 2024, then surged by 170.59% to $138.0 million in 2025, then declined by 0.72% to $137.0 million in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $137.0 million, $138.0 million, and $51.0 million for Q1 2026, Q1 2025, and Q1 2024 respectively.